• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

10.52 +0.21 (+2.04%)
Streaming Delayed Price Updated: 11:13 AM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
PRTA Stock Earnings: Prothena Corp Misses EPS, Misses Revenue for Q1 2024 ↗
May 08, 2024
PRTA stock results show that Prothena Corp missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Prothena Reports First Quarter 2024 Financial Results and Business Highlights
May 08, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
Prothena to Report First Quarter 2024 Financial Results on May 8
May 01, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
April 15, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
Demystifying Prothena Corp: Insights From 8 Analyst Reviews ↗
March 13, 2024
 
Via Benzinga
News headline image
Decoding 6 Analyst Evaluations For Prothena Corp ↗
February 16, 2024
 
Via Benzinga
News headline image
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback ↗
March 28, 2024
The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting. 
Via Investor's Business Daily
News headline image
Prothena to Participate in Upcoming Healthcare Conferences
March 05, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
Prothena Appoints David Ford to Newly Created Chief People Officer Position
March 04, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
February 29, 2024
 
Via Benzinga
News headline image
Prothena Corp: Q4 Earnings Insights ↗
February 15, 2024
 
Via Benzinga
News headline image
Earnings Scheduled For February 15, 2024 ↗
February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. 
Via Benzinga
News headline image
Earnings Outlook For Prothena Corp ↗
February 14, 2024
 
Via Benzinga
News headline image
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate
February 21, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
February 15, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
February 08, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
Navigating 5 Analyst Ratings For Prothena Corp ↗
January 25, 2024
 
Via Benzinga
News headline image
$100 Invested In Prothena Corp 5 Years Ago Would Be Worth This Much Today ↗
January 22, 2024
 
Via Benzinga
News headline image
Demystifying Prothena Corp: Insights From 5 Analyst Reviews ↗
January 09, 2024
 
Via Benzinga
News headline image
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
January 30, 2024
Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales 
Via Benzinga
News headline image
Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
January 09, 2024
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) shares fell sharply in pre-market... 
Via Benzinga
Topics Stocks
News headline image
4 Analysts Have This to Say About Prothena Corp ↗
December 18, 2023
 
Via Benzinga
News headline image
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
January 08, 2024
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
January 08, 2024
 
Via Benzinga
News headline image
Boeing, Pacific Biosciences of California And Other Big Stocks Moving Lower On Monday ↗
January 08, 2024
U.S. stocks traded mixed, with the Dow Jones index falling around 80 points on Monday. Shares of The Boeing Company (NYSE: BA) fell during Friday’s session after an exit door blew out of a 737 aircraft... 
Via Benzinga
Topics Stocks
News headline image
Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs
January 08, 2024
From Prothena Corporation plc
Via Business Wire
News headline image
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others ↗
November 21, 2023
Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins (white matter) from the brain have sparked a renewed interest in developing vaccines to combat this  
Via Benzinga
News headline image
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning ↗
November 17, 2023
Biotech companies are edging closer to finding the answers behind Alzheimer's disease. 
Via Investor's Business Daily
News headline image
8 Health Care Stocks Whale Activity In Today's Session ↗
November 07, 2023
 
Via Benzinga
News headline image
Prothena Reports Third Quarter 2023 Financial Results and Business Highlights
November 02, 2023
From Prothena Corporation plc
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap